{"id":65034,"date":"2025-02-25T12:01:40","date_gmt":"2025-02-25T12:01:40","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/25\/syndax-announces-participation-in-march-investor-conferences\/"},"modified":"2025-02-25T12:01:40","modified_gmt":"2025-02-25T12:01:40","slug":"syndax-announces-participation-in-march-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/","title":{"rendered":"Syndax Announces Participation in March Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"justify\">WALTHAM, Mass., Feb.  25, 2025  (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:6pt; margin-bottom:5pt; text-align:justify;\"><strong>TD Cowen 45th Annual Health Care Conference <\/strong>in Boston, MA, with a fireside chat on Tuesday, March 4, 2025, at 3:10 p.m. ET<\/li>\n<li style=\"margin-top:6pt; margin-bottom:5pt; text-align:justify;\"><strong>Barclays 27th Annual Global Healthcare Conference<\/strong> in Miami Beach, FL, with a fireside chat on Thursday, March 13, 2025, at 8:30 a.m. ET<\/li>\n<\/ul>\n<p align=\"justify\">A live webcast of the fireside chats will be available in the Investor section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jeFcnjL8F22rfQYWcMBxk35X0gIiS_GojUFECGfdcDC0mmWwVflrRoyw0ljtMqhxG3v6eqOeaVT1T2MNgvMnGA==\" rel=\"nofollow\" target=\"_blank\" title=\"www.syndax.com\">www.syndax.com<\/a>, where a replay will also be available for a limited time.<\/p>\n<p align=\"justify\"><strong>About Syndax<\/strong><\/p>\n<p align=\"justify\">Syndax Pharmaceuticals\u00a0is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company&#8217;s pipeline include Revuforj<sup>\u00ae<\/sup> (revumenib), an FDA-approved menin inhibitor, and Niktimvo&#x2122; (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jeFcnjL8F22rfQYWcMBxkyg4gVSydi7c652m1rXmk6O2c0Ow541u977CwtzAtY4ZMquJn2CjIdggmbvCJ3k13A==\" rel=\"nofollow\" target=\"_blank\" title=\"www.syndax.com\/\">www.syndax.com\/<\/a> or follow the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VA_BW1ovChOsYL7U56ZwA9rz6GZU0H28gNDilC6LWO41erz3oPgeh-TqBUf7NOQQWIfeX-KlyEHm1Hnt6QBbWw==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xMuu400bRclS8oyJbZeQ_rcu0iNw6XKppvPivrMqg40n4T22EBTCDc5VZ0n3bh0JduZke_Bp8J7B76-Dl6fPpQDZBy3fKacQ1ZwldB6MBBFE3rUHsglBRjQco6a3Wbiu\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p><strong>Syndax Contacts<\/strong><\/p>\n<p>Sharon Klahre<br \/>Syndax Pharmaceuticals, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=37h4aRCJj2hwbhfvQz-sahJgiWBGltDiNwB_08rBqT_myllPv4tWI1RhWwebmLjufxseTScWeJvXz5OS-5eAX6dIpqsgAEEQh4prZcBhqec=\" rel=\"nofollow\" target=\"_blank\" title=\"sklahre@syndax.com\">sklahre@syndax.com<\/a><br \/>Tel 781.684.9827<\/p>\n<p>SNDX-G<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTdiZjlhYjktOGY3MS00YWJmLTk3NTgtNzIyN2U0MTVjZTc5LTEwMTY0MTI=\/tiny\/Syndax-Pharmaceuticals-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as members of the Syndax management team, will participate in the following upcoming investor conferences: TD Cowen 45th Annual [&#8230;]\n","protected":false},"author":1,"featured_media":65035,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-65034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Syndax Announces Participation in March Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syndax Announces Participation in March Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T12:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Syndax-Pharmaceuticals-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Syndax Announces Participation in March Investor Conferences\",\"datePublished\":\"2025-02-25T12:01:40+00:00\",\"dateModified\":\"2025-02-25T12:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/\"},\"wordCount\":234,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/\",\"name\":\"Syndax Announces Participation in March Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-25T12:01:40+00:00\",\"dateModified\":\"2025-02-25T12:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syndax Announces Participation in March Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Syndax Announces Participation in March Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Syndax Announces Participation in March Investor Conferences","og_description":"WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing","og_url":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-25T12:01:40+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Syndax-Pharmaceuticals-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Syndax Announces Participation in March Investor Conferences","datePublished":"2025-02-25T12:01:40+00:00","dateModified":"2025-02-25T12:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/"},"wordCount":234,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/","name":"Syndax Announces Participation in March Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-25T12:01:40+00:00","dateModified":"2025-02-25T12:01:40+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/syndax-announces-participation-in-march-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Syndax Announces Participation in March Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=65034"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65034\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/65035"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=65034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=65034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=65034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}